在低值设置中,只注射重叠布普伦诺芬启动协议
Richard C Waters1,2, Jeremy Hoog1, Carson Bell1
1Downtown Emergency Service Center, Seattle, Washington.
JAMA network open
|August 15, 2025
概括
一个新的注射性布普伦诺芬协议显示,在使用芬太尼的人群中治疗阿片类药物使用障碍 (OUD) 是有前途的,包括那些经历无家可归的人. 在低门设置中,观察到高的启动,完成和保留率.
科学领域:
- 成 药物 药物 药物 药物
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 开始治疗阿片类药物使用障碍 (OUD) 的布普伦诺芬对芬太尼使用者来说是个挑战,特别是那些经历无家可归的人.
- 新的布普伦诺芬启动策略对于这一群体至关重要.
研究的目的:
- 为了评估一个只注射可用的重叠布普伦诺啡的短期结果,启动协议.
- 评估该协议在OUD和活跃芬太尼使用者的低门现场环境中的有效性.
主要方法:
- 使用电子健康记录进行的回顾性观察队列研究 (2024年9月 - 2025年1月).
- 包括使用芬太尼的中度至重度OUD患者在一个低值的城市OUD治疗计划中.
- 使用了只注射可用的重叠布普伦诺芬协议,而不需要停止使用芬太尼.
主要成果:
- 95人符合纳入标准;90%的人启动了协议.
- 75%的人完成了该方案,64%的人实现了2个月的保留.
- 研究的人群中,无家可归者占主导地位 (79%).
结论:
- 只有注射剂的重叠布普伦诺芬协议显示了高的启动,完成和保留率.
- 这种新的协议是一个有希望的策略,可以在门诊环境中为芬太尼使用者,包括无家可归者,启动布普伦诺芬.
- 低门,基于现场的护理促进了获得OUD治疗的机会.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
419
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
419
Drug Delivery: Miscellaneous Routes
466
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
466
Drug Delivery: Parenteral Route
821
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
821
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
146
In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration.
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
146
Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K
Opioid Receptors: Overview
1.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.8K


